New Delhi, May 21 (UNI) Country's largest pharmaceutical firm Ranbaxy Laboratories Ltd today said it has commenced its operation in Yemen, introducing its products to around 350 Doctors.
''Yemen is an important market for us. Our endeavour is to partner in bringing down the health care cost in Yemen by providing value-added international quality products at affordable prices,'' said Ranbaxy Senior Vice President and Regional Director (Asia and CIS) Sanjeev I Dani in a statement.
Ranbaxy tied up with Pharma Ltd (Natco) as business partners for its Yemen operations.
Ranbaxy has robust plans for the Yemen pharmaceutical market and will focus on therapy areas such as anti-infectives, gastro-intestinal, cholesterol lowering and anti-allergic therapeutic categories.
Ranbaxy is the first Indian company to have established such a major presence in West Asia with a strong presence in 11 countries.
It has a strong product pipeline with 160 approvals till date in the region.
Other West Asian countries where Ranbaxy has a presence are Kuwait, Bahrain, Qatar, Lebanon, Iran, Iraq, Jordan, Syria and Afghanistan.
UNI SR PDT US1939